Wegovy (semaglutide) has a list price of $1,349 per month — but that is not what most uninsured patients pay. Novo Nordisk’s self-pay programs, manufacturer pricing changes in mid-2026, and competing GLP-1 options from Eli Lilly have created a more complex cash-pay landscape than any single number captures. SunnyPharma breaks down every legitimate option for patients without insurance coverage in 2026.
Without insurance, the cheapest access to brand-name Wegovy is through NovoCare Pharmacy: $199/month for the first two fills of injections (intro offer through June 30, 2026), then $349/month. The oral pill starts at $149/month for lower doses through August 31, 2026, then $199–$299/month by dose. Uninsured patients with low income may qualify for Wegovy at no cost through Novo Nordisk’s Patient Assistance Program.
Pricing changes in mid-2026 — read before you fill: The NovoCare injection intro offer ($199/month for 0.25 mg and 0.5 mg doses) expires June 30, 2026. From July 1, the standard self-pay price for all injection doses is $349/month. The pill intro offer ($149/month for 1.5 mg and 4 mg doses) expires August 31, 2026 — after which the 4 mg dose rises to $199/month. The 9 mg and 25 mg pill doses are $299/month at any time.
NovoCare Pharmacy — The Cheapest Brand-Name Option Without Insurance
NovoCare Pharmacy is Novo Nordisk’s direct-to-consumer dispensing service. For patients without insurance — or whose insurance does not cover Wegovy — it offers the lowest available brand-name price, well below retail pharmacies. You need a valid prescription; NovoCare handles fulfillment and delivery.
Wegovy Injection (Self-Pay via NovoCare)
| Period | Doses | Monthly Cost | Notes |
|---|---|---|---|
| Through June 30, 2026 | 0.25 mg, 0.5 mg | $199 | Intro offer for first 2 fills. New to Wegovy or no fill in past 365 days. |
| From July 1, 2026 | All doses (0.25–2.4 mg) | $349 | Standard self-pay price. Applies to all doses including maintenance 2.4 mg. |
| Wegovy HD 7.2 mg | 7.2 mg | $399 | Higher dose pen. Standard self-pay, no intro pricing. |
Wegovy Pill (Self-Pay via NovoCare)
| Dose | Through Aug 31, 2026 | From Sep 1, 2026 | Notes |
|---|---|---|---|
| 1.5 mg tablet | $149/mo | $149/mo | Starter dose. Price unchanged after Aug 31. |
| 4 mg tablet | $149/mo | $199/mo | Intro offer expires Aug 31, 2026. |
| 9 mg tablet | $299/mo | $299/mo | No intro pricing at this dose. |
| 25 mg tablet | $299/mo | $299/mo | Maintenance dose. No intro pricing. |
To enroll: visit NovoCare.com or call 1-888-693-4686. Your prescriber submits the prescription directly. Home delivery is included. Self-pay pricing is not available to patients covered by government insurance programs (Medicare, Medicaid, TRICARE, VA).
Wegovy vs. Zepbound Without Insurance — Side-by-Side
If you are uninsured and considering a GLP-1 for weight loss, Wegovy (semaglutide) and Zepbound (tirzepatide) are the two FDA-approved injectable options. Both have manufacturer direct-pay programs that bring costs far below retail. The comparison matters because Zepbound’s LillyDirect program may offer a lower price at higher doses.
| Wegovy (semaglutide) | Zepbound (tirzepatide) | |
|---|---|---|
| Manufacturer | Novo Nordisk | Eli Lilly |
| FDA approval (weight loss) | June 2021 | November 2023 |
| Self-pay program | NovoCare Pharmacy | LillyDirect |
| Self-pay price range | $149–$399/mo (by form and dose) | $299–$449/mo vials (Dec 2025 pricing) |
| Pill available? | Yes — FDA approved Dec 2025 | No (injection only for self-pay) |
| Average weight loss (trials) | ~15% body weight (STEP trials) | ~22% body weight (SURMOUNT trials) |
| Self-pay program notes | Pen device via mail; intro pricing with expiry dates | Single-dose vials require self-administration with syringe; requires valid Rx |
The decision between Wegovy and Zepbound for an uninsured patient is not purely cost-based — it involves your medical history, prescriber’s recommendation, and which drug your telehealth or clinic provider can prescribe. If your insurance covers one but not the other, that tips the decision. Discuss the full picture with your prescriber before choosing based on price alone.
Compounded Semaglutide Without Insurance
Compounded semaglutide from telehealth platforms runs $99–$400/month in 2026 — significantly cheaper than NovoCare’s brand-name pricing. It is legal when a licensed prescriber identifies a clinical basis for compounding (a specific dose not commercially available, or an added ingredient such as B12), and the pharmacy is a licensed 503A or 503B facility.[1]
What it is not: compounded semaglutide is not FDA-approved, not bioequivalent-tested against branded Wegovy, not covered by insurance, and not covered under the Medicare GLP-1 Bridge. The FDA has issued safety communications about dosing errors and sterility risks.[1]
To verify a compounding pharmacy before use: check the NABP searchable database at nabp.pharmacy. Only use telehealth services that require a real clinical evaluation — not questionnaire-only prescribing.
Important: The FDA declared the semaglutide shortage resolved in 2025. 503B outsourcing facilities can no longer compound copies of branded Wegovy under shortage exemption. 503A pharmacies may still compound for patients with a documented personalization need — but the landscape for compounded GLP-1s has narrowed. Confirm current legal status with your prescriber before starting a compounded program.
Wegovy Patient Assistance Program — No Insurance, Low Income
Novo Nordisk operates a Patient Assistance Program (PAP) for uninsured or underinsured patients who cannot afford Wegovy. If you qualify, you may receive medication at no cost. Eligibility is income-based — generally up to a defined percentage of the federal poverty level, which Novo Nordisk adjusts periodically.[2]
To apply: visit NovoCare.com or call 1-888-693-4686. Your prescriber must participate in the application. Eligibility runs 12 months with annual renewal. Confirm current income thresholds directly with Novo Nordisk at time of application — criteria change.
If you do not qualify for the PAP, additional assistance may be available through:
- NeedyMeds (needymeds.org) — tracks manufacturer PAPs and discount programs including Novo Nordisk’s current eligibility criteria
- RxAssist (rxassist.org) — independent PAP screener with eligibility verification
- Patient Advocate Foundation — case management for patients facing coverage denials or cost barriers
Retail Pharmacy Cash Prices — Why They Are Not Your Best Option
At a standard retail pharmacy (CVS, Walgreens, Rite Aid), Wegovy’s cash price runs $1,229–$1,646/month depending on location, even with GoodRx coupons. GoodRx reduces the retail price by approximately 10% but cannot bring it close to NovoCare direct pricing.
The reason to use a retail pharmacy despite the higher cost: same-day local pickup. If you need a fill urgently and cannot wait for NovoCare’s mail delivery, a retail pharmacy with a GoodRx coupon is the fastest option. In all other circumstances, NovoCare direct ($349/month post-June 30) is significantly cheaper.
GoodRx and NovoCare direct cannot be combined. They are separate programs — using one means the other does not apply.
Frequently Asked Questions
How much does Wegovy cost without insurance in 2026?
Without insurance, Wegovy’s retail list price is $1,349/month. Through NovoCare Pharmacy (Novo Nordisk’s direct program), uninsured patients pay $199/month for the first two injectable fills through June 30, 2026, then $349/month. The oral pill starts at $149/month for lower doses through August 31, 2026, then $199–$299/month depending on dose. Low-income uninsured patients may qualify for the Novo Nordisk PAP at no cost.
What is the cheapest way to get Wegovy without insurance?
The cheapest legitimate options in order: (1) Novo Nordisk PAP — $0 for qualifying low-income uninsured patients; (2) NovoCare pill — $149/month through August 31, 2026 for lower doses, then $199–$299/month; (3) NovoCare injection — $199/month intro through June 30, then $349/month; (4) Compounded semaglutide — $99–$400/month but not FDA-approved. Retail pharmacy cash prices ($1,229–$1,646/month with GoodRx) are significantly higher than NovoCare direct.
Does the NovoCare self-pay price change in 2026?
Yes — materially. The injection intro offer ($199/month for 0.25 mg and 0.5 mg doses) expires June 30, 2026. From July 1, all injection doses cost $349/month through NovoCare. The pill intro offer ($149/month for 1.5 mg and 4 mg doses) expires August 31, 2026 — the 4 mg dose rises to $199/month after that date. The 9 mg and 25 mg pill doses are $299/month at any time. Novo Nordisk reserves the right to modify these programs.
Is Wegovy or Zepbound cheaper without insurance?
At starter doses, Wegovy’s pill ($149/month through August 31) is cheaper than Zepbound’s LillyDirect vials ($299–$449/month). At maintenance doses after the Wegovy intro offers expire, Wegovy injections ($349/month) and Zepbound vials ($299–$449/month) are comparable depending on dose. Zepbound has shown higher average weight loss in trials (~22% vs ~15% for Wegovy) but requires self-administration via vial and syringe rather than a pen device. The right choice depends on your clinical profile — discuss with your prescriber.
Can I get Wegovy for free without insurance?
Potentially — through Novo Nordisk’s Patient Assistance Program. Qualifying uninsured patients with low income may receive Wegovy at no cost. To apply, contact NovoCare at 1-888-693-4686 or visit novocare.com. Your prescriber must be involved in the application. NeedyMeds (needymeds.org) and RxAssist (rxassist.org) can also help you identify your eligibility and navigate the application process.
How much does the Wegovy pill cost without insurance?
Through NovoCare Pharmacy: $149/month for the 1.5 mg and 4 mg doses through August 31, 2026 (the 4 mg dose rises to $199/month after that). The 9 mg and 25 mg maintenance doses are $299/month at any time. The pill requires a daily dose taken on an empty stomach 30 minutes before the first meal of the day. No refrigeration needed. At retail pharmacies without NovoCare, the pill’s cash price tracks near the injection’s retail price — significantly higher than NovoCare direct.
Is compounded semaglutide a safe alternative to Wegovy without insurance?
Compounded semaglutide is legal under specific circumstances — a licensed 503A pharmacy with a prescriber-identified personalization need — and runs $99–$400/month, making it the cheapest available option by price. It is not FDA-approved, not bioequivalence-tested against Wegovy, and not covered by insurance. The FDA has issued safety alerts about dosing errors and sterility risks. If you choose a compounded option, verify the pharmacy at nabp.pharmacy and only use services requiring a real clinical evaluation. With the semaglutide shortage now resolved, the legal basis for some compounded programs has narrowed — confirm current status with your prescriber.
Can I use GoodRx for Wegovy without insurance?
Yes, but it is not your best option in most cases. GoodRx coupons reduce Wegovy’s retail price by approximately 10% — from $1,349 down to roughly $1,229–$1,646/month depending on pharmacy and location. NovoCare direct ($349/month for injections, $149–$299/month for the pill) is significantly cheaper. GoodRx and NovoCare cannot be combined. The main reason to use GoodRx is same-day local pharmacy pickup if you cannot wait for NovoCare mail delivery.
Does Medicaid cover Wegovy for uninsured or low-income patients?
Medicaid coverage for Wegovy for weight loss varies by state. As of January 2026, only 13 states cover GLP-1 medications for obesity under Medicaid — down from 16 in 2025. If you are uninsured and income-eligible for Medicaid, applying for your state’s Medicaid program is worth considering as a first step before using self-pay programs. Use healthcare.gov to check eligibility. If your state’s Medicaid does not cover Wegovy for weight loss, the Novo Nordisk PAP or NovoCare self-pay are your next options.
How we reviewed this article:
Pricing sourced directly from Novo Nordisk’s NovoCare Pharmacy program terms, Wegovy.com, and Walgreens Weight Management (June 2026). Compounded semaglutide legal status sourced from FDA safety communications and NABP guidance. Patient assistance eligibility sourced from NeedyMeds and RxAssist databases. We use only primary or institutional sources and update pricing on a rolling basis as manufacturer programs change.
Read our editorial policy →Sources & References
- FDA. Safety Communication: Dosing Errors with Compounded Injectable Semaglutide Products. 2025. fda.gov
- Novo Nordisk. Patient Assistance Program — NovoCare. 2026. novocare.com
- Novo Nordisk. Wegovy Self-Pay Pricing and Savings Programs. June 2026. wegovy.com
- GoodRx. Wegovy Prices and Coupons 2026. goodrx.com
- Walgreens Weight Management. Wegovy Self-Pay Program Terms. June 2026. walgreens.com
- Eli Lilly. LillyDirect Zepbound Self-Pay Pricing. December 2025. lillydirect.com
- NeedyMeds. Novo Nordisk Patient Assistance Programs. 2026. needymeds.org
- NABP. Verified Pharmacy Program. 2026. nabp.pharmacy